FIELD: medicine. SUBSTANCE: ophthalmologic agent contains riboflavin, potassium iodide, glucose, dry polyglucine, nipagine, purified water. Sterile solution of proposed agent is affected by lyophilization. EFFECT: improves desired agent quality.
Title | Year | Author | Number |
---|---|---|---|
OPHTHALMOLOGIC AGENT | 1992 |
|
RU2007152C1 |
OPHTHALMIC PREPARATION AND METHOD OF ITS PREPARING | 2000 |
|
RU2197246C2 |
CROSS-LINKING OPHTHALMIC AGENT | 2009 |
|
RU2412707C1 |
OPHTHALMIC CROSS-LINKING AGENT-2 | 2012 |
|
RU2475248C1 |
METHOD OF COLLAGEN PREPARING | 1993 |
|
RU2076718C1 |
OPHTHALMIC AGENT FOR TRANSEPITHELIAL ULTRAVIOLET CORNEAL COLLAGEN CROSSLINKING | 2014 |
|
RU2560669C1 |
DROPS FOR TREATMENT OF EYE INFLAMMATORY DISEASES (VARIANTS) | 1998 |
|
RU2149611C1 |
REPARATIVE OPHTHALMIC MEDICINAL COMPOSITION | 2009 |
|
RU2402315C2 |
OPHTHALMOLOGICAL MEANS FOR ULTRAVIOLET CORNEAL CROSSLINKING | 2016 |
|
RU2646452C1 |
EYE DROPS BASED ON PHARMACEUTICALLY TOLERABLE ADDITIVE SALTS OF ACID AND METHYL ETHYL ENCEPHABOL CONTAINING COMPOSITION OF VITAMINS B | 2013 |
|
RU2528912C1 |
Authors
Dates
1994-06-15—Published
1992-10-01—Filed